HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prophylaxis against Neisseria meningitidis infections and antibody responses in patients with deficiency of the sixth component of complement.

Abstract
Forty South African patients with homozygous deficiency of the sixth component of complement (C6) have been identified in an area where group B meningococcal meningitis is endemic; 22 of the 24 proband cases presented with recurrent meningococcal meningitis. In a 2- to 4-year prospective study, patients with recurrent infections who received monthly prophylactic long-acting penicillin were significantly protected from subsequent neisserial infection compared with those who did not receive penicillin (P = .02, Fisher's exact test). Heterogeneous susceptibility to neisserial infection was confirmed by following C6-deficient patients who presented with one or no Neisseria meningitidis infections. These patients, on no prophylaxis, had significantly fewer infections (P = .004) than did patients who presented with recurrent disease. Functional C6 activity was restored by transfusion of fresh frozen plasma in a C6-deficient patient resistant to conventional antibiotic treatment. Antibody levels to the serotype 2 outer membrane proteins were significantly elevated in C6-deficient patients compared with control groups (P = .001).
AuthorsP C Potter, C E Frasch, W J van der Sande, R C Cooper, Y Patel, A Orren
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 161 Issue 5 Pg. 932-7 (May 1990) ISSN: 0022-1899 [Print] United States
PMID2109021 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Bacterial
  • Bacterial Outer Membrane Proteins
  • Complement C6
  • Penicillin G
  • Penicillin G Benzathine
Topics
  • Antibodies, Bacterial (biosynthesis)
  • Bacterial Outer Membrane Proteins (immunology)
  • Child
  • Child, Preschool
  • Complement C6 (deficiency)
  • Disease Susceptibility
  • Follow-Up Studies
  • Humans
  • Infant
  • Meningitis, Meningococcal (prevention & control)
  • Neisseria meningitidis (immunology)
  • Penicillin G (therapeutic use)
  • Penicillin G Benzathine (therapeutic use)
  • Prospective Studies
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: